[Chemotherapy of stomatologic cancers].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000145:classification / Q000627:therapeutic use*; D003078:Colchicine / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D009062:Mouth Neoplasms / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D009808:Odontogenic Tumors / Q000188:drug therapy* / Q000473:pathology; D008517:Phytotherapy; D010908:Pituitary Hormones, Anterior / Q000627:therapeutic use; D010909:Pituitary Hormones, Posterior / Q000627:therapeutic use; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000494:pharmacology; D011035:Podophyllum / Q000627:therapeutic use; D014520:Urethane / Q000627:therapeutic use; D014747:Vinblastine; D014750:Vincristine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D010908:Pituitary Hormones, Anterior; D010909:Pituitary Hormones, Posterior; D003561:Cytarabine; D014520:Urethane; D014750:Vincristine; D014747:Vinblastine; D011033:Podophyllin; D003078:Colchicine
Chimiothérapie des cancers stomatologiques.